Showing results (161-170 of 229) with videos related to
Sort By:
Pageof 23
Diabetologia|April 8, 2010
Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot studyA M Arafat, M Möhlig, M O Weickert, et al.Aging Cell|September 5, 2024
Targeting TGF-β signaling, oxidative stress, and cellular senescence rescues osteoporosis in gerodermia osteodysplasticaW L Chan, C H Bucher, J Goldes, et al.Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|December 1, 1993
[Osteogenesis imperfecta in childhood and adolescence]R E Brenner, B Schiller, B F Pontz, et al.Journal of Medical Genetics|April 5, 2005
Distinct CDH3 mutations cause ectodermal dysplasia, ectrodactyly, macular dystrophy (EEM syndrome)K W Kjaer, L Hansen, G C Schwabe, et al.Diabetologia|May 13, 2005
A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam Study cohortC Heidemann, K Hoffmann, J Spranger, et al.American Journal of Medical Genetics|September 1, 1982
AtelosteogenesisP Maroteaux, J Spranger, V Stanescu, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 30, 2018
Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2S Butscheidt, A Delsmann, T Rolvien, et al.Osteoarthritis and Cartilage|January 21, 2020
Skeletal deterioration in COL2A1-related spondyloepiphyseal dysplasia occurs prior to osteoarthritisT Rolvien, T A Yorgan, U Kornak, et al.International Journal of Sports Medicine|January 21, 2012
Leptin and endocrine parameters in marathon runnersT Bobbert, K Mai, L Brechtel, et al.Journal of Endocrinological Investigation|May 10, 2006
Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levelsC Otto, B Otto, B Göke, et al.Pageof 23